Naltrexone Accord (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Naltrexone Accord, is an opioid antagonist presented as a tablet for oral use. It is used to support treatment of alcohol and opioid dependence in adults. GNH USA supplies Naltrexone Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexone Accord is an opioid antagonist indicated for managing substance dependence disorders. - Alcohol dependence: helps reduce cravings and supports abstinence from alcohol. - Opioid dependence: blocks opioid receptors to prevent relapse and reduce the rewarding effects of opioids. - Substance use disorder: used as part of a comprehensive treatment program to maintain sobriety.

Naltrexone Accord may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial pain. - Dizziness: sensation of light‑headedness. - Fatigue: general tiredness. - Insomnia: difficulty falling or staying asleep. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe depression: mood changes requiring medical attention. - Suicidal thoughts: emergence of suicidal ideation. - Allergic reactions: rash, itching, or swelling. - Liver failure: rare but life‑threatening hepatic dysfunction.

Before initiating therapy with Naltrexone Accord, consider the following precautions. - Liver function assessment: evaluate hepatic enzymes prior to use. - Depression monitoring: watch for worsening mood or suicidal thoughts. - Acute opioid withdrawal: avoid initiating during active withdrawal to prevent precipitated symptoms. - Renal impairment: adjust use in patients with severe kidney disease. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Naltrexone Accord can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Opioid agonists (e.g., morphine, oxycodone): may precipitate withdrawal. - Methadone or buprenorphine: can reduce therapeutic effect and cause abrupt withdrawal. - Disulfiram: combined hepatotoxic risk.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may enhance sedation. - Antidepressants (e.g., SSRIs): monitor for mood changes. - Rifampin: may increase naltrexone metabolism, reducing efficacy.